Neuron-specific enolase and S 100B protein as predictors of outcome in ischaemic stroke

Neurologia i Neurochirurgia Polska

Volumn 44, Issue 5, 2010, Pages 459-463

  Kaca Oryńska, Małgorzata ^a   Tomasiuk, Ryszard ^a   Friedman, Andrzej ^b  

^a Brodno Voivodship Hospital   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Neuron specific enolase; Predictors; S 100B protein; Stroke

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S100B;

AGED; ARTICLE; BARTHEL INDEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CHEMOLUMINESCENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANKIN SCALE; VOLUMETRY;

EID: 78149345690     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60136-5     Document Type: Article

References (22)

1. Missler U., Wiesmann M., Friedrich C., et al. S100 protein and neuron specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28: 1956-1969. (Pubitemid 27459003)
2. Hardemark H.G. S100 protein and neuron specific enolase cerebrospinal fluid markers of brain damage - clinical and experimental studies. Acta Universitas Upsaliensis, Uppsala 1988.
3. Martens P., Raabe A., Johnsson P. Serum S100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998; 29: 2363-2366. (Pubitemid 28511959)
4. Wȩglewski A., Ryglewicz D., Mular A., et al. Zmiany stȩżenia białka S100 w surowicy krwi w udarze niedokrwiennym i krwotocznym mózgu w zależności od ogniska udarowego. Neurol Neurochir Pol 2005; 39: 310-317. (Pubitemid 41195327)
5. Hermann M., Vos P., Wunderlich M.T., et al. Release of glial tissue-specific proteins after acute stroke. Stroke 2000; 31: 2670-2677.
6. Anand N., Stead L.G. Neuron specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Disord 2005; 20: 213-219. (Pubitemid 41318197)
7. Hermann M., Jost S., Kutz S., et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 2000; 17: 113-122. (Pubitemid 30120300)
8. Raabe A., Groims C., Keller M., et al. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 1998; 140: 787-791.
9. Rasmussen L.S., Christiansen M., Eliasen K., et al. Biochemical markers for brain damage after cardiac surgery-time profile and correlation with cognitive dysfunction. Acta Anaestesiol Scand 2002; 46: 547-551. (Pubitemid 34547951)
10. Gao F., Harris D.N., Sapsed-Byrne S. Nerve tissue protein S100 and neuron specific enolase concentrations in cerebral fluid and blood during carotid endarterectomy. Anaesthesia 2000; 55: 764-769. (Pubitemid 30627978)
11. Foerch C., Wunderlich M.T., Dvorak F., et al. Elevated serum S100B levels indicate higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 2007; 38: 2491-2495. (Pubitemid 47329627)
12. Oertel M., Schumacher U., McArthur D.L. S-100B and NSE: markers of initial impact of subarachnoid hemorrhage and their relation to vasospasm and outcome. J Clin Neurosci 2006; 13: 834-840. (Pubitemid 44415475)
13. van Engelen B.G., Lamers K.J., Gabreels F.J., et al. Age related changes of neuron-specific enolase, S100 protein and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem 1992; 38: 613-616.
14. Wiesmann M., Missler U., Gottmann D., et al. Plasma S100 protein concentration in health adults is age and sex-independent. Clin Chem 1998; 44: 1056-1058. (Pubitemid 28213152)
15. Nash D.L., Bellolio M.F., Stead L.G. S100 as a marker of acute brain ischemia: a systematic review. Neurocrit Care 2008; 8: 301-307.
16. Hay E., Royds J.A., Aelwyn G. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry 1984; 47: 724-729.
17. Cunningham R.T., Young I.S. Serum neuron specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991; 21: 497-500.
18. Jauch E.C., Lindsell C., Broderick J. Association of serial biochemical markers with acute ischemic stroke. Stroke 2006; 37: 2508-2513.
19. Wunderlich M.T., Lins H., Skalej M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg 2006; 108: 558-563. (Pubitemid 44189097)
20. Persson L., Hardemark H.G., Gustafsson J. S100 protein and neuron specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18: 911-918. (Pubitemid 17126635)
21. Oh S.H., Lee J. Prediction of early clinical severity and extent of neronal damage in anterior circulation infarction using the initial serum neuron specific enolase level. Arch Neurol 2003; 60: 37-41. (Pubitemid 36078106)
22. Sienkiewicz-Jarosz H., Gałecka-Wolska M., Bidziński A., et al. Predictive value of selected biochemical markers of brain damage for functional outcome in ischaemic stroke patients. Neurol Neurochir Pol 2009; 2: 126-133.